MO24-2 Clinical outcomes of tyrosine kinase inhibitors immediately after immune checkpoint inhibitors in renal cell carcinomaTaigo Kato,Akira Nagahara,Norihiko Kawamura,Wataru Nakata,Tetsuji Soda, Kyousuke Matsuzaki,Koji Hatano,Atsunari Kawashima,Takeshi Ujike,Kensaku Nishimura,Shingo Takada,Masao Tsujihata,Seiji Yamaguchi,Tetsuya Takao,Yasutomo Nakai,Masashi Nakayama,Motohide Uemura,Norio NonomuraAnnals of Oncology(2022)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要